Association of patterns of care, prognostic factors, and use of radiotherapy –temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study
ConclusionIn non-progressive patients, prolonging the adjuvant temozolomide beyond 6 cycles may improve OS.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | France Health | Neurology | Study | Temodar